The role of oculoplastic surgeons in minimally invasive cosmetic injectables.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9011108 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-7021 (Electronic) Linking ISSN: 10408738 NLM ISO Abbreviation: Curr Opin Ophthalmol Subsets: MEDLINE

Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Philadelphia, PA : Current Science, c1990-

Cosmetic Techniques*/adverse effects ; Dermal Fillers*/adverse effects ; Dermal Fillers*/administration & dosage; Humans ; Minimally Invasive Surgical Procedures ; Injections ; Physician's Role ; Surgeons ; Hyaluronic Acid/administration & dosage ; Hyaluronic Acid/adverse effects

Purpose of Review: In recent years, the field of aesthetic medicine has witnessed a paradigm shift with an increasing demand for minimally invasive cosmetic procedures, including cosmetic injectables. This review aims to delineate the distinctive role played by oculoplastic surgeons in the administration of cosmetic injectables, comparing their expertise to that of nonphysician practitioners.
Recent Findings: Complications arising from cosmetic injections are discussed, including skin discoloration, inflammation, necrosis, vision loss, retinal pathology, and central nervous system adverse effects. Injector expertise, patient factors, type of filler, location of injection, and management strategies are reviewed. Findings highlight diverse practitioner involvement, common adverse effects like skin necrosis and vision loss, with hyaluronic acid fillers being prominent. Areas at the highest risk for ocular complication include the glabella and nose with potential management involving dissolving fillers and reducing pressure. Emphasis is placed on expert injector selection and patient awareness.
Summary: The administration of cosmetic injectables requires a profound understanding of facial anatomy, vasculature, and potential complications. In contrast to nonphysician practitioners, oculoplastic and aesthetic surgeons bring a level of anatomical precision and clinical acumen that is essential for navigating the complexities of cosmetic injectables. Emphasis on training and collaboration among practitioners will be essential in advancing the field while prioritizing patient safety and satisfaction.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)

Sito G, Manzoni V, Sommariva R. Vascular complications after facial filler injection: a literature review and meta-analysis. J Clin Aesthet Dermatol 2019; 12:E65.
Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Plast Surg Nurs 2015; 35:13–32.
Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthetic Surg J 2011; 31:110–121.
Ricci LH, Navajas SV, Carneiro PR, et al. Ocular adverse effects after facial cosmetic procedures: a review of case reports. J Cosmet Dermatol 2015; 14:145–151.
Lazzeri D, Agostini T, Figus M, et al. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012; 129:995–1012.
Gart MS, Gutowski KA. Overview of botulinum toxins for aesthetic uses. Clin Plast Surg 2016; 43:459–471.
Kim KK, Granick MS, Baum GA, et al. American Society of Plastic Surgeons evidence-based clinical practice guideline: eyelid surgery for upper visual field improvement. Plast Reconstr Surg 2022; 150:419E–434E.
Clark NW, Pan DR, Barrett DM. Facial fillers: relevant anatomy, injection techniques, and complications. World J Otorhinolaryngol Head Neck Surg 2023; 9:227.
Trinh LN, Gupta A. Hyaluronic acid fillers for midface augmentation: a systematic review. Facial Plast Surg 2021; 37:576–584.
Jordan DR. Soft-tissue fillers for wrinkles, folds and volume augmentation. Can J Ophthalmol 2003; 38:285–288.
Skippen B, Baldelli I, Hartstein M, et al. Rehabilitation of the dysmorphic lower eyelid from hyaluronic acid filler: what to do after a good periocular treatment goes bad. Aesthetic Surg J 2020; 40:197–205.
Few J, Cox SE, Paradkar-Mitragotri D, Murphy DK. A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years. Aesthetic Surg J 2015; 35:589–599.
Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am 2015; 23:479–488.
Sarah Crowley J, Kream E, Fabi S, Cohen SR. Facial rejuvenation with fat grafting and fillers. Aesthetic Surg J 2021; 41: (Suppl 1): S31–S38.
Sung WI, Tsai S, Chen LJ. Ocular complications following cosmetic filler injection. JAMA Ophthalmol 2018; 136:e180716–e1180716.
Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2004; 7:211–228.
Lee W, Koh IS, Oh W, Yang EJ. Ocular complications of soft tissue filler injections: a review of literature. J Cosmet Dermatol 2020; 19:772–781.
Mortada H, Seraj H, Barasain O, et al. Ocular complications post-cosmetic periocular hyaluronic acid injections: a systematic review. Aesthetic Plast Surg 2022; 46:760–773.
Zein M, Tie-Shue R, Pirakitikulr N, Lee WW. Complications after cosmetic periocular filler: prevention and management. Plast Aesthetic Res 2020; 7:44.
Agorgianitis L, Panagouli E, Tsakotos G, et al. The supratrochlear artery revisited: an anatomic review in favor of modern cosmetic applications in the area. Cureus 2020; 12:e7141.
Wu S, Pan L, Wu H, et al. Anatomic study of ophthalmic artery embolism following cosmetic injection. J Craniofac Surg 2017; 28:1578–1581.
Liao ZF, Cong LY, Hong WJ, et al. Three-dimensional computed tomographic study of the supratrochlear artery and supraorbital artery to determine arterial variations and their relationship. Dermatol Surg 2022; 48:225–231.
Wollina U, Goldman A. Facial vascular danger zones for filler injections. Dermatol Ther 2020; 33:e14285.
Aziz SR, Marchena JM, Puran A. Anatomic characteristics of the infraorbital foramen: a cadaver study. J Oral Maxillofac Surg 2000; 58:992–996.
Scheuer JF, Sieber DA, Pezeshk RA, et al. Facial danger zones: techniques to maximize safety during soft-tissue filler injections. Plast Reconstr Surg 2017; 139:1103–1108.
Hu XZ, Hu JY, Wu P, et al. Posterior ciliary artery occlusion caused by hyaluronic acid injections into the forehead: a case report. Med (Baltimore) 2016; 95:e3124.
Kwon DY, Park MH, Koh SB, et al. Multiple arterial embolism after illicit intranasal injection of collagenous material. Dermatol Surg 2010; 36:1196–1199.
Oh B-L, Jung C, Park H, et al. Therapeutic intra-arterial hyaluronidase infusion for ophthalmic artery occlusion following cosmetic facial filler (hyaluronic acid) injection. Neuro Ophthalmol 2014; 38:39–43.
Myung Y, Yim S, Jeong JH, et al. The classification and prognosis of periocular complications related to blindness following cosmetic filler injection. Plast Reconstr Surg 2017; 140:61–64.
He MS, Sheu MM, Huang ZL, et al. Sudden bilateral vision loss and brain infarction following cosmetic hyaluronic acid injection. JAMA Ophthalmol 2013; 131:1234–1235.
Kassir R, Kolluru A, Kassir M. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature. J Cosmet Dermatol 2011; 10:224–231.
Park TH, Seo SW, Kim JK, Chang CH. Clinical experience with hyaluronic acid-filler complications. J Plast Reconstr Aesthetic Surg 2011; 64:892–896.
Lee CM, Hong IH, Park SP. Ophthalmic artery obstruction and cerebral infarction following periocular injection of autologous fat. Korean J Ophthalmol 2011; 25:358–361.
Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 2008; 121:1811–1820.
Sung MS, Kim HG, Woo K, Kim YD. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthal Plast Reconstr Surg 2010; 26:289–291.
Bellman B. Complication following suspected intra-arterial injection of restylane. Aesthetic Surg J 2006; 26:304–305.
Kim SG, Lee CJ, Kim YJ, Lee S Il. Salvage of nasal skin in a case of venous compromise after hyaluronic acid filler injection using prostaglandin e. Dermatologic Surg 2011; 37:1817–1819.
Grunebaum LD, Allemann IB, Dayan S, et al. The risk of alar necrosis associated with dermal filler injection. Dermatologic Surg 2009; 35: (Suppl 2): 1635–1640.
Kwon SG, Hong JW, Roh TS, et al. Ischemic oculomotor nerve palsy and skin necrosis caused by vascular embolization after hyaluronic acid filler injection: a case report. Ann Plast Surg 2013; 71:333–334.
Kim YJ, Kim SS, Song WK, et al. Ocular ischemia with hypotony after injection of hyaluronic acid gel. Ophthal Plast Reconstr Surg 2011; 27:e152–e155.
Kim SK, Kim JH, Hwang K. Skin necrosis of the nose after injection of ribose cross-linked porcine atelocollagen. J Craniofac Surg 2015; 26:2211–2212.
McGuire L, Hale E, Godwin L. Post-filler vascular occlusion: a cautionary tale and emphasis for early intervention. J Drugs Dermatol 2013; 12:.
Tracy L, Ridgway J, Nelson JS, et al. Calcium hydroxylapatite associated soft tissue necrosis: a case report and treatment guideline. J Plast Reconstr Aesthetic Surg 2014; 67:564–568.
Humphrey CD, Arkins JP, Dayan SH. Soft tissue fillers in the nose. Aesthetic Surg J 2009; 29:477–484.
Steinsapir KD, Steinsapir SMG. Deep-fill hyaluronic acid for the temporary treatment of the naso-jugal groove: a report of 303 consecutive treatments. Ophthal Plast Reconstr Surg 2006; 22:344–348.
Ozturk CN, Li Y, Tung R, et al. Complications following injection of soft-tissue fillers. Aesthetic Surg J 2013; 33:862–877.
Rayess HM, Svider PF, Hanba C, et al. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg 2018; 20:207–214.
Alharbi MM, Bin Dlaim MS, Alqahtani JM, et al. Ophthalmic complications of periorbital and facial aesthetic procedures: a literature review. Cureus 2023; 15:.
Cohen JL, Biesman BS, Dayan SH, et al. Treatment of hyaluronic acid filler-induced impending necrosis with hyaluronidase: consensus recommendations. Aesthetic Surg J 2015; 35:844–849.
Kleydman K, Cohen JL, Marmur E. Nitroglycerin: a review of its use in the treatment of vascular occlusion after soft tissue augmentation. Dermatol Surg 2012; 38:1889–1897.
Carley SK, Kraus CN, Cohen JL. Nitroglycerin, or not, when treating impending filler necrosis. Dermatol Surg 2020; 46:31–40.
Hwang CJ, Morgan PV, Pimentel A, et al. Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG Imaging. Ophthal Plast Reconstr Surg 2016; 32:118–122.
Darling MD, Peterson JD, Fabi SG. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatologic Surg 2014; 40:1049–1052.
Jalilian F, Hetz SP, Bostwick J, Boet S. Hyperbaric oxygen therapy for treatment of a late presenting ischaemic complication from hyaluronic acid cosmetic filler injection. BMJ Case Rep 2022; 15:e249190.
Kruize RGF, Teguh DN, Van Hulst RA. Hyperbaric oxygen therapy in hyaluronic acid filler-induced dermal ischemia. Dermatol Surg 2020; 46:1755–1757.
Carruthers JDA, Fagien S, Rohrich RJ, et al. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 2014; 134:1197–1201.
Tulius M, Silva-Rua T, Silva T, Land Curi A. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 2004; 62:873–874.
Kubota T, Hirose H. Permanent loss of vision following cosmetic rhinoplastic surgery. Jpn J Ophthalmol 2005; 49:535–536.
Kim SN, Byun DS, Park JH, et al. Panophthalmoplegia and vision loss after cosmetic nasal dorsum injection. J Clin Neurosci 2014; 21:678–680.
Roberts SAI, Arthurs BP. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection. Ophthal Plast Reconstr Surg 2012; 28:e68–e70.
Vu PQ, Grob SR, Tao JP. Light perception vision recovery after treatment for calcium hydroxylapatite cosmetic filler-induced blindness. Ophthal Plast Reconstr Surg 2018; 34:e189–e192.
Kato JM, Matayoshi S. Visual loss after aesthetic facial filler injection: a literature review on an ophthalmologic issue. Arq Bras Oftalmol 2021; 85:309–319.
Walker L, Convery C, Davies E, et al. Consensus opinion for the management of soft tissue filler induced vision loss. J Clin Aesthet Dermatol 2021; 14:E84.
Sharudin SN, Ismail MF, Mohamad NF, Vasudevan SK. Complete recovery of filler-induced visual loss following subcutaneous hyaluronidase injection. Neuro Ophthalmol 2019; 43:102.
Wang J, Shen H, Liu T, et al. An efficacy and safety study of intra-arterial recanalization of occluded ophthalmic arteries in patients with monocular blindness caused by injection of hyaluronic acid in facial tissues. Aesthetic Plast Surg 2021; 45:1573–1578.
Xu X, Zhou G, Fu Q, et al. Efficacy of intra-arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization. J Cosmet Dermatol 2021; 20:3205–3212.
Zhang LX, Lai LY, Zhou GW, et al. Evaluation of intraarterial thrombolysis in treatment of cosmetic facial filler-related ophthalmic artery occlusion. Plast Reconstr Surg 2020; 145:42E–50E.
Xiao H, Kou W, Yang Y, et al. Administration method and potential efficacy of hyaluronidase for hyaluronic acid filler-related vision loss: a systematic review. Aesthetic Plast Surg 2024; 48:709–718.
van Loghem J, Funt D, Pavicic T, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: an expert consensus. J Cosmet Dermatol 2020; 19:2845.
Downie EM, Chen Y, Lucarelli MJ, Burkat CN. Isolated ophthalmoplegia following filler injections to the upper face. Ophthal Plast Reconstr Surg 2020; 36:e152–e154.
Kim EG, Eom TK, Kang SJ. Severe visual loss and cerebral infarction after injection of hyaluronic acid gel. J Craniofac Surg 2014; 25:684–686.
Wang HC, Yu N, Wang X, et al. Cerebral embolism as a result of facial filler injections: a literature review. Aesthetic Surg J 2022; 42:N162–N175.

0 (Dermal Fillers)
9004-61-9 (Hyaluronic Acid)

Date Created: 20240627 Date Completed: 20240808 Latest Revision: 20240808

20240808

10.1097/ICU.0000000000001068

38934244